Beneficial effects of atorvastatin on lung structural remodeling and function in Ischemic heart failure

Journal of Cardiac Failure

Volumn 16, Issue 8, 2010, Pages 679-688

  Jiang, Bao Hua ^a   Tardif, Jean Claude ^a   Sauvageau, Stephanie ^a   Ducharme, Anique ^a   Shi, Yanfen ^a   Martin, James G ^b   Dupuis, Jocelyn ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Drugs; heart failure; hypertension; lung; pulmonary; pulmonary heart disease; remodeling

Indexed keywords

ATORVASTATIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; IN VIVO STUDY; ISCHEMIC HEART FAILURE; LUNG FUNCTION; LUNG PRESSURE; LUNG STRUCTURE; LUNG WEIGHT; MYOFIBROBLAST; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 77955516735     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.03.003     Document Type: Article

References (34)

1. S.V. Abramson, J.F. Burke, J.J. Kelly Jr., J.G. Kitchen 3rd, M.J. Dougherty, and D.F. Yih Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy Ann Intern Med 116 1992 888 895
2. J. Butler, D.B. Chomsky, and J.R. Wilson Pulmonary hypertension and exercise intolerance in patients with heart failure J Am Coll Cardiol 34 1999 1802 1806
3. S. Ghio, A. Gavazzi, C. Campana, C. Inserra, C. Klersy, and R. Sebastiani Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 2001 183 188
4. B.K. Gehlbach, and E. Geppert The pulmonary manifestations of left heart failure Chest 125 2004 669 682
5. J.F. Jasmin, A. Calderone, T.K. Leung, L. Villeneuve, and J. Dupuis Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan Cardiovasc Res 58 2003 621 631
6. T. Nishimura, J.L. Faul, G.J. Berry, L.T. Vaszar, D. Qiu, and R.G. Pearl Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats Am J Respir Crit Care Med 166 2002 1403 1408
7. K.L. Watts, and M.A. Spiteri Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism Am J Physiol Lung Cell Mol Physiol 287 2004 L1323 L1332
8. S.E. Alexeeff, A.A. Litonjua, D. Sparrow, P.S. Vokonas, and J. Schwartz Statin use reduces decline in lung function: VA Normative Aging Study Am J Respir Crit Care Med 176 2007 742 747
9. J.M. Foody, R. Shah, D. Galusha, F.A. Masoudi, E.P. Havranek, and H.M. Krumholz Statins and mortality among elderly patients hospitalized with heart failure Circulation 113 2006 1086 1092
10. A.S. Go, W.Y. Lee, J. Yang, J.C. Lo, and J.H. Gurwitz Statin therapy and risks for death and hospitalization in chronic heart failure JAMA 296 2006 2105 2111
11. K.K. Khush, D.D. Waters, V. Bittner, P.C. Deedwania, J.J. Kastelein, and S.J. Lewis Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study Circulation 115 2007 576 583
12. I. Gissi-Hf Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1231 1239
13. J. Kjekshus, E. Apetrei, V. Barrios, M. Bohm, J.G.F. Cleland, and J.H. Cornel Rosuvastatin in Older Patients with Systolic Heart Failure N Engl J Med 357 2007 2248 2261 (Pubitemid 350190755)
14. Q.T. Nguyen, F. Colombo, J.L. Rouleau, J. Dupuis, and A. Calderone LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction Br J Pharmacol 130 2000 1525 1530
15. S.E. Litwin, S.E. Katz, J.P. Morgan, and P.S. Douglas Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat Circulation 89 1994 345 354
16. C. Tei, K.S. Dujardin, D.O. Hodge, K.R. Bailey, M.D. McGoon, and A.J. Tajik Doppler echocardiographic index for assessment of global right ventricular function J Am Soc Echocardiogr 9 1996 838 847
17. Q.T. Nguyen, F. Colombo, R. Clement, H. Gosselin, J.L. Rouleau, and A. Calderone AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI Br J Pharmacol 138 2003 1485 1494
18. F. Lefebvre, A. Prefontaine, A. Calderone, A. Caron, J.F. Jasmin, and L. Villeneuve Modification of the pulmonary renin-angiotensin system and lung structural remodelling in congestive heart failure Clin Sci (Lond) 111 2006 217 224
19. A. Prefontaine, A. Calderone, and J. Dupuis Role of endothelin receptors on basal and endothelin-1-stimulated lung myofibroblast proliferation Can J Physiol Pharmacol 86 2008 337 342
20. J.K. Liao Isoprenoids as mediators of the biological effects of statins J Clin Invest 110 2002 285 288
21. B. Hinz, S.H. Phan, V.J. Thannickal, A. Galli, M.L. Bochaton-Piallat, and G. Gabbiani The myofibroblast: one function, multiple origins Am J Pathol 170 2007 1807 1816
22. C.J. Scotton, and R.C. Chambers Molecular targets in pulmonary fibrosis: the myofibroblast in focus Chest 132 2007 1311 1321
23. J. Dupuis, A. Prefontaine, L. Villeneuve, N. Ruel, F. Lefebvre, and A. Calderone Bone marrow-derived progenitor cells contribute to lung remodelling after myocardial infarction Cardiovasc Pathol 16 2007 321 328
24. M.P. Kingsbury, W. Huang, J.L. Donnelly, E. Jackson, E. Needham, and M.A. Turner Structural remodelling of lungs in chronic heart failure Basic Res Cardiol 98 2003 295 303
25. Y. Kapanci, S. Burgan, G.G. Pietra, B. Conne, and G. Gabbiani Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension Am J Pathol 136 1990 881 889
26. K. Frazier, S. Williams, D. Kothapalli, H. Klapper, and G.R. Grotendorst Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor J Invest Dermatol 107 1996 404 411
27. A. Ben Driss, C. Devaux, D. Henrion, M. Duriez, C. Thuillez, and B.I. Levy Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure Circulation 101 2000 2764 2770
28. Y. Rikitake, and J.K. Liao Rho GTPases, statins, and nitric oxide Circ Res 97 2005 1232 1235
29. C.Y. Wang, P.Y. Liu, and J.K. Liao Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends Mol Med 14 2008 37 44
30. P.F. Mount, B.E. Kemp, and D.A. Power Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation J Mol Cell Cardiol 42 2007 271 279
31. J.C. Parker, and M.I. Townsley Evaluation of lung injury in rats and mice Am J Physiol Lung Cell Mol Physiol 286 2004 L231 L246
32. M. Guazzi Alveolar-capillary membrane dysfunction in chronic heart failure: pathophysiology and therapeutic implications Clin Sci (Lond) 98 2000 633 641
33. A.A. Smith, P.J. Cowburn, M.E. Parker, M. Denvir, S. Puri, and K.R. Patel Impaired pulmonary diffusion during exercise in patients with chronic heart failure Circulation 100 1999 1406 1410
34. S. Puri, B.L. Baker, D.P. Dutka, C.M. Oakley, J.M. Hughes, and J.G. Cleland Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance Circulation 91 1995 2769 2774